On August 17, 2022 DAVA Pharmaceuticals, LLC and affiliates filed for chapter 11 protection in the Southern District of New York (Case No. 22-22558). The Debtor reports Assets of $1B-$10B and Liabilities of $1B-$10B. The Petition states funds will be available to Unsecured Creditors.